Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children

Transplantation

Volumn 77, Issue 7, 2004, Pages 1096-1100

  Jacobsohn, David A ^a,b   Schechter, Tali ^a,b   Seshadri, Roopa ^a,b   Thormann, Kimberly ^a,b   Duerst, Reggie ^a,b   Kletzel, Morris ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EOSINOPHILIA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; TH2 CELL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EOSINOPHILIA; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 1942471959     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000118409.92769.FA     Document Type: Article

References (12)

1. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204.
2. Kalaycioglu ME, Bolwell BJ. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen. Bone Marrow Transplant 1994; 14: 113.
3. Przepiorka D, Anderlini P, Saliba R, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695.
4. Tanaka J, Imamura M, Kasai M, et al. Th2 cytokines (IL-4, IL-10 and IL-13) and IL-12 mRNA expression by concanavalin A-stimulated peripheral blood mononuclear cells during chronic graft-versus-host disease. Eur J Haematol 1996; 57: 111.
5. Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219.
6. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406.
7. Arslan O, Akan H, Koc H, et al. Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen. Bone Marrow Transplant 1996; 18: 261.
8. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787.
9. Daneshpouy M, Socie G, Lemann M, et al. Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood 2002; 99: 3033.
10. Basara N, Kiehl MG, Fauser AA. Eosinophilia indicates the evolution to acute graft-versus-host disease. Blood 2002; 100: 3055.
11. McNeel D, Rubio MT, Damaj G, et al. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation 2002; 74: 1797.
12. Thomson AW, Milton JI, Aldridge RD, et al. Inhibition of drug-induced eosinophilia by cyclosporin A. Scand J Immunol 1986; 24: 163.